Table 2a
Table 2a: Proteasome and proteases inhibitors that inhibit Rel/NF-kB
Molecule | References |
Proteasome inhibitors | |
Peptide Aldehydes: | Palombella et al, 1994; Grisham et al, 1999; Jobin et al, 1998 |
ALLnL
(N-acetyl-leucinyl-leucynil-norleucynal, MG101) |
|
LLM (N-acetyl-leucinyl-leucynil-methional) | |
Z-LLnV
(carbobenzoxyl-leucinyl-leucynil-norvalinal,MG115) |
|
Z-LLL
(carbobenzoxyl-leucinyl-leucynil-leucynal, MG132) |
|
MG262 | Pujois et al, 2012 |
Lactacystine, beta-lactone | Fenteany & Schreiber, 1998; Grisham et al, 1999 |
Boronic Acid Peptide | Grisham et al, 1999; Iqbal et al, 1995 |
Dithiocarbamate complexes with metals | Cvek & Dvorak, 2007 |
CEP-18770 | Piva et al, 2007 |
Ubiquitin Ligase Inhibitors | Yaron et al, 1997 |
PS-341 (Bortezomib) | Adams, 2004 |
Salinosporamide A (1, NPI-0052) | Macherla et al, 2005; Ahn et al, 2007 |
Cyclosporin A | Frantz et al, 1994; Kunz et al, 1995; Marienfeld et al, 1997; McCaffrey et al, 1994;Meyer et al, 1997; Wechsler et al, 1994 |
FK506 (Tacrolimus) | Okamoto et al, 1994; Venkataraman et al, 1995 |
Deoxyspergualin | Tepper et al, 1995 |
Disulfiram | Lovborg et al, 2005 |
PT-110 | Momose et al, 2007 |
Protease inhibitors | |
APNE (N-acetyl-DL-phenylalanine-b-naphthylester) | Higuchi et al, 1995 |
BTEE (N-benzoyl L-tyrosine-ethylester) | Rossi et al, 1998 |
DCIC (3,4-dichloroisocoumarin) | D’Acquisto et al, 1998 |
DFP (diisopropyl fluorophosphate) | |
TPCK (N-a-tosyl-L-phenylalanine chloromethyl ketone) | |
TLCK (N-a-tosyl-L-lysine chloromethyl ketone) |